You just read:

Mitsubishi Tanabe Pharma Group Companies To Present New Data On Investigational Oral Formulation Of Edaravone For ALS At 29th International Symposium On ALS/MND

News provided by

Mitsubishi Tanabe Pharma America, Inc.

Nov 15, 2018, 07:30 ET